Knowledge Center
Article / 2014
Pharmaceutical Manufacturing and Supply-Chain Trends to 2020
Source:
Pharmaceutical Technology Europe, August 2014
A breach in the pharmaceutical supply chain is only the tip of the iceberg.
Innovators (Big Pharma and biotech companies) are today a minority player supplying only about 20% of the world’s medicines. At present, the vast majority of medicines are generic—the fruits of the best science of the 20th century can now be enjoyed for a few cents a pill.
Innovators (Big Pharma and biotech companies) are today a minority player supplying only about 20% of the world’s medicines. At present, the vast majority of medicines are generic—the fruits of the best science of the 20th century can now be enjoyed for a few cents a pill.
Related links
Also in the Knowledge Center
Poster / May 03, 2022
Use of PAT tools in the development, monitor and control of continuous manufacturing processes
Read more
Scientific Article
Poster / May 03, 2022
Enhancing the “right first time” concept in Continuous Manufacturing – Development strategy
Read more
Scientific Article
Scientific Article